Efficacy of leupeptin in treating ischemia in a rat hind limb model

Abstract Prolonged tourniquet use can lead to tissue ischemia and can cause progressive muscle and nerve injuries. Such injuries are accompanied by calpain activation and subsequent Wallerian‐like degeneration. Several known inhibitors, including leupeptin, are known to impede the activity of calpai...

Full description

Bibliographic Details
Main Authors: Mikhail Gurevich, Kari Iocolano, Irene Nozal Martin, Gurtej Singh, Sami U. Khan, Duc T. Bui, Alexander B. Dagum, David E. Komatsu
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:Physiological Reports
Subjects:
Online Access:https://doi.org/10.14814/phy2.15411
_version_ 1797397306631258112
author Mikhail Gurevich
Kari Iocolano
Irene Nozal Martin
Gurtej Singh
Sami U. Khan
Duc T. Bui
Alexander B. Dagum
David E. Komatsu
author_facet Mikhail Gurevich
Kari Iocolano
Irene Nozal Martin
Gurtej Singh
Sami U. Khan
Duc T. Bui
Alexander B. Dagum
David E. Komatsu
author_sort Mikhail Gurevich
collection DOAJ
description Abstract Prolonged tourniquet use can lead to tissue ischemia and can cause progressive muscle and nerve injuries. Such injuries are accompanied by calpain activation and subsequent Wallerian‐like degeneration. Several known inhibitors, including leupeptin, are known to impede the activity of calpain and associated tissue damage. We hypothesize that employment of leupeptin in a rat model of prolonged hind limb ischemia can mitigate muscle and nerve injuries. Sprague–Dawley rats (n = 10) weighing between 300–400 g were employed in this study. Their left hind limbs were subjected to blood flow occlusion for a period of 2‐h using a neonatal blood pressure cuff. Five rats were given twice weekly intramuscular leupeptin injections, while the other five received saline. After 2 weeks, the animals were euthanized, their sciatic nerves and gastrocnemius muscles were harvested, fixed, stained, and analyzed using NIH Image J software. The administration of leupeptin resulted in larger gastrocnemius muscle fiber cross‐sectional areas for the right (non‐tourniquet applied) hindlimb as compared to that treated with the saline (p = 0.0110). However, no statistically significant differences were found between these two groups for the injured left hindlimb (p = 0.1440). With regards to the sciatic nerve cross‐sectional areas and sciatic functional index, no differences were detected between the leupeptin and control treated groups for both the healthy and injured hindlimbs. This research provides new insights on how to employ leupeptin to inhibit the degenerative effects of calpain and preserve tissues following ischemia resulting from orthopedic or plastic surgery procedures.
first_indexed 2024-03-09T01:08:57Z
format Article
id doaj.art-c65009e583fb408b8b87bc6673c47e0a
institution Directory Open Access Journal
issn 2051-817X
language English
last_indexed 2024-03-09T01:08:57Z
publishDate 2022-08-01
publisher Wiley
record_format Article
series Physiological Reports
spelling doaj.art-c65009e583fb408b8b87bc6673c47e0a2023-12-11T09:10:41ZengWileyPhysiological Reports2051-817X2022-08-011015n/an/a10.14814/phy2.15411Efficacy of leupeptin in treating ischemia in a rat hind limb modelMikhail Gurevich0Kari Iocolano1Irene Nozal Martin2Gurtej Singh3Sami U. Khan4Duc T. Bui5Alexander B. Dagum6David E. Komatsu7Renaissance School of Medicine Stony Brook New York USAStony Brook University Stony Brook New York USADivision of Plastic and Reconstructive Surgery, Department of Surgery Stony Brook University Hospital Stony Brook New York USADivision of Plastic and Reconstructive Surgery, Department of Surgery Stony Brook University Hospital Stony Brook New York USADivision of Plastic and Reconstructive Surgery, Department of Surgery Stony Brook University Hospital Stony Brook New York USADivision of Plastic and Reconstructive Surgery, Department of Surgery Stony Brook University Hospital Stony Brook New York USADivision of Plastic and Reconstructive Surgery, Department of Surgery Stony Brook University Hospital Stony Brook New York USADepartment of Orthopaedics and Rehabilitation Stony Brook University Hospital New York USAAbstract Prolonged tourniquet use can lead to tissue ischemia and can cause progressive muscle and nerve injuries. Such injuries are accompanied by calpain activation and subsequent Wallerian‐like degeneration. Several known inhibitors, including leupeptin, are known to impede the activity of calpain and associated tissue damage. We hypothesize that employment of leupeptin in a rat model of prolonged hind limb ischemia can mitigate muscle and nerve injuries. Sprague–Dawley rats (n = 10) weighing between 300–400 g were employed in this study. Their left hind limbs were subjected to blood flow occlusion for a period of 2‐h using a neonatal blood pressure cuff. Five rats were given twice weekly intramuscular leupeptin injections, while the other five received saline. After 2 weeks, the animals were euthanized, their sciatic nerves and gastrocnemius muscles were harvested, fixed, stained, and analyzed using NIH Image J software. The administration of leupeptin resulted in larger gastrocnemius muscle fiber cross‐sectional areas for the right (non‐tourniquet applied) hindlimb as compared to that treated with the saline (p = 0.0110). However, no statistically significant differences were found between these two groups for the injured left hindlimb (p = 0.1440). With regards to the sciatic nerve cross‐sectional areas and sciatic functional index, no differences were detected between the leupeptin and control treated groups for both the healthy and injured hindlimbs. This research provides new insights on how to employ leupeptin to inhibit the degenerative effects of calpain and preserve tissues following ischemia resulting from orthopedic or plastic surgery procedures.https://doi.org/10.14814/phy2.15411calpainischemialeupeptinstourniquetsvascular system injuries
spellingShingle Mikhail Gurevich
Kari Iocolano
Irene Nozal Martin
Gurtej Singh
Sami U. Khan
Duc T. Bui
Alexander B. Dagum
David E. Komatsu
Efficacy of leupeptin in treating ischemia in a rat hind limb model
Physiological Reports
calpain
ischemia
leupeptins
tourniquets
vascular system injuries
title Efficacy of leupeptin in treating ischemia in a rat hind limb model
title_full Efficacy of leupeptin in treating ischemia in a rat hind limb model
title_fullStr Efficacy of leupeptin in treating ischemia in a rat hind limb model
title_full_unstemmed Efficacy of leupeptin in treating ischemia in a rat hind limb model
title_short Efficacy of leupeptin in treating ischemia in a rat hind limb model
title_sort efficacy of leupeptin in treating ischemia in a rat hind limb model
topic calpain
ischemia
leupeptins
tourniquets
vascular system injuries
url https://doi.org/10.14814/phy2.15411
work_keys_str_mv AT mikhailgurevich efficacyofleupeptinintreatingischemiainarathindlimbmodel
AT kariiocolano efficacyofleupeptinintreatingischemiainarathindlimbmodel
AT irenenozalmartin efficacyofleupeptinintreatingischemiainarathindlimbmodel
AT gurtejsingh efficacyofleupeptinintreatingischemiainarathindlimbmodel
AT samiukhan efficacyofleupeptinintreatingischemiainarathindlimbmodel
AT ductbui efficacyofleupeptinintreatingischemiainarathindlimbmodel
AT alexanderbdagum efficacyofleupeptinintreatingischemiainarathindlimbmodel
AT davidekomatsu efficacyofleupeptinintreatingischemiainarathindlimbmodel